Find in Library

Purpose: Salvage cystectomy is performed when recurrences or treatment failures occur or curative treatment for bladder cancer is not possible . In this article, we aimed to present our experience of salvage cystectomies in light of current literature. Material and Methods: Folders of patients underwent salvage cystectomy between August 2011 and May 2013 were compared according to demographics, pre and post operative pathology reports, complicatons and types of urinary divertion. Results: Mean follow-up was 10,3 (3-20,8) months. When pathologies were compared by peroperative transurethral resection (TUR), 2 (18.1%) patients were T1, 8 (%72.7) patients were T2, 1 (9%) patient was T4; pathology specimens following cystectomy was T2 in 4 (36.3%), T3 in 3 (27.2%) and T4 in 4 (36.3%) patients. 1 patient had squamous cell carcinoma, 2 patients had lymph node metastasis. 1 patient suffered from bleeding, one patient sufferd from ileal extravasation, 1 suffered from urine extravasation and one patient suffered from infection in early postoperative period (<90 days). 2 patients had anastomosis stricture after 90 days. 2 patients had to be managed by radiotherapy because of recurrent mass and metastasis. One patient died because of cardiopulmonary issues and one patient died from cirrhosis. Conclusion: Even though it is associated with higher risk of complications, salvage cystectomy can be performed with acceptable morbidity and mortality rates.